胰腺癌扩大根治术中的血管处理

目的 探讨联合门静脉-肠系膜上静脉切除的胰腺癌扩大根治术的临床意义和手术方法 ,以及术中医源性血管损伤的处理方法 .方法 回顾性分析242例胰腺癌扩大根治术患者临床资料,所有患者分为三组,A组为门静脉/肠系膜上静脉切除组(n=51),B组为术中发生医源性血管损伤组(n=5),C组为未行血管处理组(n=186),比较三个组的手术时间、术中输血量、血管阻断时间、平均住院天数、术后并发症及术后生存分析.结果 三个组手术时间分别为(442.85±102.32)min、(348.62±92.31)min和(315.00±83.43)min,术中平均输血量为(1430.83±1092.43)ml、(1420.22±794.41 ml)和(928.19±571.57)ml,手术时间和术中输血量相比差异有统计学意义(P<0.05),平均住院天数、术后并发症发生率差异无统计学意义(P 0.05).合并门静脉/肠系膜上静脉切除的胰腺腺癌患者术后中位生存期18.4个月,不合并门静脉/肠系膜上静脉切除组的胰腺腺癌患者术后中位生存期16.1个月,生存分析两者无明显差异(P 0.05).51例联合血管切除的患者中,行血管壁部分切除7例,行血管节段切除44例,44例血管节段切除患者中38例行端端吻合,6例行间置移植物,血管切除长度平均(2.92±1.35)cm;5例术中医源性动脉损伤的血管分别为肝动脉1例,肠系膜上动脉1例,腹腔干3例,处理方式为4例行端端吻合,1例行局部修补.结论 积极合理的开展联合门静脉/肠系膜上静脉切除的胰腺癌扩大根治术可以提高手术切除率,改善患者生活质量.由于局部的解剖关系复杂,术中较易发生医源性血管损伤,应引起术者重视并加以正确处理.

The management of vasculature during extended radical resection for pancreatic cancer

Objective To explore the clinical significance and operational methods during extended radical excision for pancreatic cancer combined with portal vein ( PV )/superior mesentery vein ( SMV ) resection,and to investigate the management of iatrogenic arterial injury. Methods Clinical date of 242 patients with pancreatic cancer undergoing extended radical excision were retrospectively analyzed. All cases were divided into three groups, patients with PV/SMV resection were in group A (n = 51 ), patients with iatrogenic arterial injury during operation were in group B(n =5) ,patients without resection of vessels werein group C (n = 186 ). Operating time、volume of intraoperative blood transfusion, time of vascular interruption、the mean hospitalization,postoperative complications and postoperative survival analysis among three groups were compared with each other. Results Operating time in group A、B and C were (442. 85 ± 102. 32 ) min, ( 348. 62 ± 92. 31 ) min and ( 315.00 ± 83.43 ) min respectively, volume of intraoperative blood transfusion were ( 1430. 83 ± 1092. 43 ) ml、( 1420. 22 ± 794. 41 ) ml and ( 928. 19 ±571.57) ml respectively,operating time and volume of intraoperative blood transfusion were of significantly difference(P <0. 05) among the 3 groups,there was no significant difference in the mean hospitalization and postoperative complications. The postoperative median survival period was 18.4 months for patients of pancreatic adenocarcinoma with PV/SMV resection, the postoperative median survival period was 16. 1 months without PV/SMV resection, there was no significant difference between these by postoperative survival analysis. In the 51 cases with vessel resection,7 cases underwent partial resection of the vascular wall,44 cases underwent segmental resection, reconstruction of the portal vein was performed by end-to-end anastomosis in 38 patients, stent graft in 6 cases, the mean length of the PV/SMV resection was (2. 92 ±1.35 ) cm; latrngenic arterial injury occurred during operation in 5 patients ( 1 in hepatic artery, 1 in superior mesenteric artery, 3 in celiac think), the artery was reconstructed by end-to-end anastomosis in 4 cases,repair in 1 case. Conclusions Active and reasonable operation for pancreatic cancer with PV/SMV resection is important for improving the rate of surgical resection and the quality of life. Because of complex topography,iatrogenic vascular injury may happened frequently.